已收盤 10-16 16:00:00 美东时间
+0.050
+0.26%
Barclays analyst Richard Hightower maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Equal-Weight and lowers the price target from $23 to $21.
10-14 00:32
今日重点评级关注:杰富瑞:维持拜玛林制药"买入"评级,目标价从104美元升至105美元;RBC Capital:维持Shift4 Payments"跑赢大市"评级,目标价从63美元升至67美元
09-01 08:37
Baird analyst Vikram Malhotra maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $20 to $21.
08-31 19:50
Life360暴泻18.99%;USA Rare Earth急跌7.98%;Rocket Lab急跌7.02%
08-11 08:06
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Raymond James analyst David Rodgers upgraded Sabra Health Care REIT Inc (NASDAQ:SBRA) from Underp...
08-06 20:15
Raymond James analyst David Rodgers upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Underperform to Market Perform.
08-06 17:44
Sabra Health Care (SBRA) declares $0.30/share quarterly dividend, in line with previous. Forward yield 5.82% Payable Aug. 31; for shareholders of record Aug. 14; ex-div Aug. 14. See SBRA Dividend Scor...
08-04 16:38
华盛资讯8月4日讯,Sabra Health Care REIT, Inc.公布2026财年Q2业绩,公司Q2营收2.36亿美元,同比增长24.7%,归母净利润亏损0.25亿美元,由盈转亏。
08-04 06:18
华盛资讯8月4日讯,Sabra Health Care REIT, Inc.公布2026财年Q2业绩,公司Q2营收2.36亿美元,同比增长24.9%,归母净利润亏损0.25亿美元,由盈转亏。
08-04 04:35